McCrimmon, Tara
Witte, Susan
Mergenova, Gaukhar
Terlikbayeva, Assel
Primbetova, Sholpan
Kuskulov, Azamat
Bellamy, Scarlett L.
El-Bassel, Nabila
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA036514)
Article History
Received: 4 May 2017
Accepted: 27 February 2018
First Online: 20 March 2018
Ethics approval and consent to participate
: This trial was approved by Columbia University’s Institutional Review Board (IRB), and by the Ethics Committee of the Kazakhstan School of Public Health (KSPH).Informed consent was conducted verbally with all study participants before taking part in screening for study eligibility. A written consent form was reviewed with all eligible participants before they completed the initial assessments.This study was funded to Drs. El-Bassel (PI) and Susan Witte (PI). The grant number is: R01 DA036514. The funder was not involved in study design or analysis.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.